I was honestly thinking the same thing… if only I could just buy swaps that kick off 12% a year with zero vol.
Keeping the usual 13.7% slice in gold & bitcoin has been a drag these past few months. @wisdomtreefunds @JeremyDSchwartz

HSBC: The hike before Christmas Strong jobs and inflation hovering around 3% have pushed markets to price in about 75bp of hikes. We’re not convinced the Fed will turn more hawkish than that, though: growth is leaning heavily on AI-driven capex, and tech-sector profits still aren’t translating into broad-based hiring.

回撤幅度一览(Drawdowns): $INTC -58% $ARM -58% $MRVL -52% $KLAC -50% $ORCL -50% $AMAT -50% $LRCX -48% $BABA -48% $NFLX -47% $CAT -44% $DELL -42% $SPCX -38% $MU -38% $SKHY -34% $NVDA -33% $GEV -33% $AVGO -30% $GOOG -28% $ASML -25% $TSLA -22% $PLTR -21% $AMD -19% $TSM -18% $META -18% 数据来源:@finviz_com

Goldman is penciling in 2.4% US real GDP growth in 2027, alongside 1.4% headline CPI (2.2% core PCE). They also see the 10-year yield drifting down to 4.4% over the next 12 months.

$NVDA is down 32% from the peak… the question is, how much further does this drawdown have to run? @koyfincharts

For a midterm year, 2026 has been pretty calm so far… The S&P 500 (SPX) is up +11.54% on a total-return basis through last week, and the biggest drawdown has been just 9% (JPMAM).

If I were 64, a private health insurance premium would run about $1,500 a month. Assuming a steady annual increase over the next 26 years, that math puts it around $22,000 a month right before Medicare kicks in.
But dividend income… it’s the steady, often overlooked part of the return profile—especially when you zoom out and look at how it behaves across cycles.
Right now it’s $570/month for health/dental/vision—works out to about $369/month once the S-corp tax perks are factored in (HSA contribution included).
$KO Coca-Cola is trading at 28.6x P/E — its highest level since 2002 (via @koyfincharts).

Consumer Staples P/E is at its highest level in 27 years… what’s driving it? $WMT $COST $KO at 28x isn’t cheap either $PG at 22.9x (via @finviz_com)

$NVDA’s trailing price-to-sales has cratered—from over 45x down to about 13x (@augurinfinity). Forward P/S: ~5.55x.
